Patent · US Active

Azetidine derivatives

US8530460B2 · kind B2 · utility

0Cited by

0References

11Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Martin Fleck · Warthausen, DE
Bernd Nosse · Biberach an der Riß, DE
Niklas Heine · Eberhardzell, DE
Gerald Juergen Roth · Biberach, DE

Key dates

Filing date	Dec 14, 2012
Grant date	Sep 10, 2013
Priority date	—
Expiry date	Dec 14, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D498/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Azetidine derivatives of which the following is exemplaryand their use in the treatment of obesity, diabetes or dyslipidemia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.